Live from ClinicalTrials.gov + Open Targets, fetched 2026-11-12 00:42 UTC. Every row links to its source record.
Postmortem · what the sponsor and named sources said, kept apart from what merely happened at the same time
Anti-chlamydophila Antibiotic Combination Therapy in the Treatment of Patients With Coronary Heart Disease
NCT03618108 · Cadrock Pty. Ltd. · PHASE2 · terminated · last registry update 2021-08-02 · Decision brief
No research has been run for this trial yet, so only the registry's own reason and the timeline are shown.
What was said, and by whom
Stated is the sponsor's own words; Reported is a named third party. The category is our label from a fixed list; the quote is the evidence.
| Kind | Quote | Our category | Source |
|---|---|---|---|
| Stated | “COVID-19” | – | Registry record, Cadrock Pty. Ltd. |
Also happening at the time. Not shown to be a cause.
Registry events on other trials of drugs against MMP7 within 12 months either side of this trial's last update, live from ClinicalTrials.gov. Nothing here was stated as a reason.
- 2022-07-26Phase 3 first posted: National University Hospital, Singapore, Doxycycline + Placebo (NCT05473520)
- 2022-07-20Results posted on the registry: University of California, Los Angeles, Doxycycline (NCT04167085)
- 2022-07-18Also stopped (withdrawn): Health Clinics Limited, Metabolic treatment (NCT02201381)
- 2022-07-08Phase 3 first posted: Cairo University, a drug against MMP7 (NCT05448937)
- 2022-06-01Also stopped (terminated): Wolfson Medical Center, amoxicillin, metronidazole and doxycycline + amoxicillin and doxycyclin (NCT03986996)
- 2022-05-31Also stopped (terminated): Radboud University Medical Center, Doxycycline + Trimethoprim (NCT03173053)
- 2022-05-31Phase 3 first posted: Hospital General de Mexicali, Azithromycin + Doxycycline + Placebo + Doxycycline (NCT05398055)
- 2022-05-10Results posted on the registry: Galderma R&D, Trifarotene cream + Doxycycline hyclate (NCT04451330)
- 2022-04-25Phase 3 first posted: Journey Medical Corporation, DFD-29 + Doxycycline (NCT05343455)
- 2022-04-20Also stopped (withdrawn): Nantes University Hospital, Doxycycline + Placebo (NCT04371952)
- 2022-03-25Phase 3 first posted: Journey Medical Corporation, DFD-29 + Doxycycline (NCT05296629)
- 2022-02-11Results posted on the registry: Medstar Health Research Institute, Azithromycin + Doxycycline (NCT02756403)
- 2021-12-15Phase 3 first posted: Assiut University, Doxycycline 100 mg Oral Tablet + Prednisolone 20 mg (NCT05157412)
- 2021-11-26Results posted on the registry: University of Maryland, Baltimore, Doxycycline + Placebo (NCT01756833)
- 2021-10-12Phase 3 first posted: Tourcoing Hospital, Reduction in the duration of antibiotic therapy 3 weeks or 6 weeks (NCT05074147)
- 2021-06-30Results posted on the registry: Emergent BioSolutions, Ciprofloxacin 500Mg Tablet + Doxycycline 100Mg Tablet (NCT04067011)
- 2021-06-23Results posted on the registry: Radboud University Medical Center, Doxycycline + Placebo (NCT01318356)
- 2021-04-27Also stopped (terminated): Rochester General Hospital, Doxycycline monohydrate (NCT02341209)
- 2021-04-19Also stopped (withdrawn): Temple University, Doxycycline + Placebo (NCT04433078)
- 2021-04-13Results posted on the registry: State University of New York - Upstate Medical University, Chloroquine + Atovaquone and Proguanil (NCT02564471)
- 2021-04-09Phase 3 first posted: Assistance Publique - Hôpitaux de Paris, BPG + Doxycycline (NCT04838717)
- 2021-04-08Also stopped (terminated): Weill Medical College of Cornell University, Antimicrobial therapy: Co-trimoxazole or Doxycycline (NCT02759120)
- 2021-04-06Also stopped (terminated): Julio Ramirez, oral antibiotics (NCT02099240)
- 2021-03-25Results posted on the registry: PATH, iOWH032 + Placebo (NCT04150250)
- 2021-03-03Results posted on the registry: Weill Medical College of Cornell University, Antimicrobial therapy: Co-trimoxazole or Doxycycline (NCT02759120)
What is not public
- Internal portfolio and board discussions
- Unpublished trial data and interim analyses
- Terms of any partner or licence decision